正道集团(01188.HK)附属与福邦正道订特许协议
正道集团(01188.HK)公布,於2019年6月9日,旗下上海贡(旦)与福邦正道订立特许协议。根据特许协议,上海贡(旦)同意特许福邦正道使用知识产权及技术知识,以於福建省设计、开发、生产及销售新能源汽车。未经上海贡(旦)事先批准,福邦正道不得将知识产权及技术知识之特许权转授予任何第三方。特许协议下之特许期为2019年6月9日至2029年6月8日。
特许协议下之特许权费为6.4亿元人民币,将於签订特许协议後90天内由福邦正道支付。特许权费不可退回。其後,福邦正道须向上海贡(旦)支付专利权费,金额按福邦正道收入之2.5%计算,将於特许期内每季结束後5天内由福邦正道支付予上海贡(旦)。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.